ReferenceID 6530

The anti-inflammatory effect of ε-viniferin by specifically targeting formyl peptide receptor 1 on human neutrophils

Chem Biol Interact

The uncontrol respiratory burst in neutrophils can lead to inflammation and tissue damage. This study investigates the effect and the underlying mechanism of epsilon-viniferin, a lignan from the root of Vitis thunbergii

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final reference record.

Reference Id
6530
Evidence Id
23120
Core Evidence Id
23120
Source Reference Id
6361
Herb2 Reference Id
HBREF007158
Subject Paper Key
HBIN049233_34144024
Pubmed Id
34144024
Doi
10.1016/j.cbi.2021.109490
Paper Title
The anti-inflammatory effect of ε-viniferin by specifically targeting formyl peptide receptor 1 on human neutrophils
Paper Abstract
The uncontrol respiratory burst in neutrophils can lead to inflammation and tissue damage. This study investigates the effect and the underlying mechanism of epsilon-viniferin, a lignan from the root of Vitis thunbergii var. thunbergii, inhibits N-formyl-L-methionyl-L-leucyl-l-phenylalanine (fMLP) induced respiratory burst by antagonizing formyl peptide receptor 1 in human neutrophils. Briefly, epsilon-viniferin specifically inhibited fMLP (0.1 muM: formyl peptide receptor 1 agonist or 1 muM: formyl peptide receptor 1, 2 agonist)-induced superoxide anion production in a concentration-dependent manner (IC50 = 2.30 +- 0.96 or 9.80 +- 0.21 muM, respectively) without affecting this induced by formyl peptide receptor 2 agonist (WKYMVM). epsilon-viniferin inhibited fMLP (0.1 muM)-induced phosphorylation of ERK, Akt, Src or intracellular calcium mobilization without affecting these caused by WKYMVM. The synergistic suppression of fMLP (1 muM)-induced superoxide anion production was observed only in the combination of epsilon-viniferin and formyl peptide receptor 2 antagonist (WRW4) but not in combination of epsilon-viniferin and formyl peptide receptor 1 antagonist (cyclosporine H). epsilon-viniferin inhibited FITC-fMLP binding to formyl peptide receptors. Moreover, the synergistic suppression of FITC-fMLP binding was observation only in the combination of epsilon-viniferin and WRW4 but not in other combinations. ATPgammaS induced superoxide anion production through formyl peptide receptor 1 in fMLP desensitized neutrophils and this effect was inhibited by epsilon-viniferin. The concentration-response curve of fMLP-induced superoxide anion was not parallel shifted by epsilon-viniferin. Furthermore, the inhibiting effect of epsilon-viniferin on fMLP-induced superoxide anion production was reversible. These results suggest that epsilon-viniferin is an antagonist of formyl peptide receptor 1 in a reversible and non-competitive manner.
Journal
Chem Biol Interact
Publish Year
2021
Experiment Subject
human; thunbergii
Experiment Type
Cell Experiment
Phenotype Related
Inflammation
Paper Title Cn
Paper Title En
The anti-inflammatory effect of ε-viniferin by specifically targeting formyl peptide receptor 1 on human neutrophils
Bilingual Status
semi_complete